Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
84 studies found for:    "Vaginal cancer"
Show Display Options
Rank Status Study
1 Completed Lymphoscintigraphy in Patients With Vaginal Cancer
Condition: Vaginal Cancer
Intervention: Procedure: Lymphoscintigraphy
2 Completed Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer
Conditions: Cervical Cancer;   Vaginal Cancer
Intervention: Drug: paclitaxel
3 Completed Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
Conditions: Cervical Cancer;   Vaginal Cancer
Interventions: Biological: therapeutic allogeneic lymphocytes;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: mycophenolate mofetil;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
4 Active, not recruiting Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina
Condition: Vaginal Cancer
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Procedure: Diffusion Weighted Magnetic Resonance Imaging (DWMR)
5 Completed Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function
Condition: Vaginal Cancer
Intervention: Behavioral: QOL
6 Completed
Has Results
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
Conditions: Recurrent Cervical Cancer;   Recurrent Vaginal Cancer;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Vaginal Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Cervical Cancer;   Stage IVB Vaginal Cancer;   Therapy-related Toxicity
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Procedure: quality-of-life assessment;   Other: questionnaire administration;   Radiation: fludeoxyglucose F 18;   Procedure: positron emission tomography;   Procedure: computed tomography
7 Recruiting Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma, Not Otherwise Specified;   Stage IB2 Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Stage IVB Vaginal Cancer
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Radiation: Radiation Therapy;   Drug: Triapine
8 Terminated Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer
Condition: Cervical Cancer
Interventions: Drug: Velcade (bortezomib);   Drug: Irinotecan
9 Active, not recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB2 Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA1 Cervical Cancer;   Stage IIA2 Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Adenosquamous Carcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: Cisplatin;   Radiation: External Beam Radiation Therapy;   Radiation: Internal Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Triapine
10 Active, not recruiting Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Condition: Cancer of the Cervix
Interventions: Drug: Granisetron;   Drug: Ondansetron;   Behavioral: Questionnaires;   Behavioral: Study Drug Diary
11 Active, not recruiting Pelvic Fractures and Radiation Therapy for Cervical Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer
Intervention: Procedure: CT or MRI + Blood Test
12 Completed Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Infection;   Perioperative/Postoperative Complications;   Vaginal Cancer
Interventions: Procedure: infection prophylaxis and management;   Procedure: management of therapy complications;   Procedure: surgical procedure
13 Withdrawn Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
Conditions: Cervical Cancer;   Endometrial Cancer;   Ovarian Cancer;   Vaginal Cancer
Interventions: Drug: capecitabine;   Radiation: brachytherapy;   Radiation: radiation therapy
14 Completed Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis
Conditions: Bladder Cancer;   Cervical Cancer;   Endometrial Cancer;   Vaginal Cancer
Interventions: Drug: paclitaxel;   Drug: vinorelbine tartrate;   Radiation: radiation therapy
15 Completed Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema
Conditions: Ovarian Cancer;   Uterine Cancer;   Vaginal Cancer;   Lymphedema
Interventions: Behavioral: limb volume measurements and GCLQ lymphedema symptom assessment questionnaire;   Behavioral: GCLQ lymphedema symptom assessment questionnaire
16 Recruiting Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brachytherapy
Conditions: Cervical Cancer;   Endometrial Cancer;   Radiation Toxicity;   Vaginal Cancer
Interventions: Other: survey administration;   Other: computer-assisted intervention;   Behavioral: telephone-based intervention
17 Completed Intensity Modulated Radiation Therapy - Gyne Cancer (GY03.2)
Conditions: Cervix Neoplasms;   Uterine Neoplasms;   Vaginal Neoplasms
Intervention: Procedure: Intensity Modulated Radiation Therapy Boost
18 Active, not recruiting Image-Guided Gynecologic Brachytherapy
Conditions: Cervical Cancer;   Uterine Cancer;   Vaginal Cancer;   Carcinoma of the Vulva
Intervention: Procedure: Image-guided brachytherapy
19 Completed Effectiveness of an Individualized Symptom Education Program (ISEP)
Conditions: Uterine Cancer;   Cervical Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Behavioral: Individualized Symptom Education
20 Completed
Has Results
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
Conditions: Cervical Cancers;   Vulvar Cancers;   Vaginal Cancers;   Genital Warts
Interventions: Biological: V503;   Biological: Placebo to V503

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.